Corporate Overview
Nanotherapeutics Corporate Overview
Nanotherapeutics has significant expertise in product formulation, pre-clinical and clinical development, scale-up and cGMP manufacturing, utilizing established as well as our proprietary techniques: NanoQUAD®, NanoDRY®, and GelVac™. Our specialized proprietary techniques can improve the release rate, enhance both the rate and extent of drug uptake, and/or increase bioavailability. The consequences of these changes include more consistent drug therapy with potentially reduced dose and dose frequency requirements, as well as fewer side effects.
Our specialized technologies, proprietary processing techniques and know-how set us apart from most other biopharmaceutical companies. Key pharmaceutical advantages of our technologies include:
- Broad applicability - Our delivery options are applicable to a diverse group of drug molecules - proteins, peptides and other poorly absorbed compounds.
- Versatility of formulation - We have created various types of injectable, inhaled/nasal, topical, and oral formulations using our particle-based delivery expertise.
- Stabilization - We have demonstrated more than twelve months of room temperature stability with different formulations - including vaccines - without loss of activity or dispersability.
- Ease of Manufacture - Scale-up to commercial quantities of production is readily obtainable at cost-effective levels.
Value Statement for Quality
Nanotherapeutics maintains a Quality Policy that allows us to set quality measures/goals to acceptable levels appropriate for each product or process and to monitor continually that such measures/goals are met or exceeded according to customer requirements. Nanotherapeutics ensures the quality and integrity of products and data generated, and continually improves quality at the source through employee involvement and supplier assessment. Nanotherapeutics provides appropriate leadership, clear vision, and focuses upon core values to ensure employee safety and well being while maintaining compliance to appropriate regulatory guidelines.